​

MiMedx Group (MDXG) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MDXG Stock Forecast

MiMedx Group (MDXG) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $11.75, with a high of $16.00 and a low of $8.00. This represents a 74.59% increase from the last price of $6.73.

$5 $8 $11 $14 $17 $20 High: $16 Avg: $11.75 Low: $8 Last Closed Price: $6.73

MDXG Stock Rating

MiMedx Group stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (71.43%), 2 Hold (14.29%), 2 Sell (14.29%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 2 2 10 Strong Sell Sell Hold Buy Strong Buy

MDXG Price Target Upside V Benchmarks

TypeNameUpside
StockMiMedx Group74.59%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$16.00
Last Closing Price$6.73$6.73$6.73
Upside/Downside--137.74%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25-5---5
Sep, 25-5---5
Aug, 25-5---5
Jul, 25-4---4
Jun, 25-5---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 15, 2024Anthony PetroneMizuho Securities$16.00$9.0976.02%137.74%
Jul 02, 2024Ross OsbornCantor Fitzgerald$11.00$6.7064.18%63.45%
Apr 29, 2024Brooks O'NeilLake Street$12.00$6.2791.39%78.31%
Sep 07, 2022H.C. Wainwright$8.00$3.42133.92%18.87%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 01, 2024Craig-HallumBuyBuyhold
Jul 02, 2024Cantor FitzgeraldOverweightinitialise

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.46$-0.09$-0.27$0.48$0.29----
Avg Forecast-$-0.17$-0.30$0.10$0.30$0.31$0.43$0.43$0.90
High Forecast-$-0.16$-0.30$0.11$0.31$0.32$0.49$0.44$0.91
Low Forecast-$-0.17$-0.30$0.10$0.28$0.29$0.37$0.43$0.89
Surprise %--47.06%-10.00%380.00%-3.33%----

Revenue Forecast

$200M $280M $360M $440M $520M $600M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$248.23M$258.62M$267.84M$321.48M$348.88M----
Avg Forecast$241.69M$254.89M$267.99M$319.81M$345.37M$377.04M$428.13M$471.80M$553.89M
High Forecast$245.54M$258.96M$270.53M$322.82M$349.31M$381.33M$428.13M$477.17M$560.20M
Low Forecast$238.92M$251.98M$266.52M$317.23M$343.70M$375.22M$428.13M$469.52M$551.21M
Surprise %2.71%1.46%-0.06%0.52%1.01%----

Net Income Forecast

$-50M $-10M $30M $70M $110M $150M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-49.28M$-10.29M$-30.20M$67.44M$42.42M----
Avg Forecast-$-12.54M$-17.82M$55.80M$42.77M$44.54M$67.20M$63.03M$131.37M
High Forecast-$-8.17M$-12.21M$72.89M$44.95M$46.66M$72.14M$63.69M$133.31M
Low Forecast-$-16.90M$-23.43M$38.70M$40.60M$42.42M$53.39M$62.37M$130.54M
Surprise %--17.96%69.42%20.87%-0.82%----

MDXG Forecast FAQ

Is MiMedx Group stock a buy?

MiMedx Group stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 2 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that MiMedx Group is a favorable investment for most analysts.

What is MiMedx Group's price target?

MiMedx Group's price target, set by 14 Wall Street analysts, averages $11.75 over the next 12 months. The price target range spans from $8 at the low end to $16 at the high end, suggesting a potential 74.59% change from the previous closing price of $6.73.

How does MiMedx Group stock forecast compare to its benchmarks?

MiMedx Group's stock forecast shows a 74.59% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for MiMedx Group over the past three months?

  • October 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is MiMedx Group’s EPS forecast?

MiMedx Group's average annual EPS forecast for its fiscal year ending in December 2025 is $0.31, marking a 6.90% increase from the reported $0.29 in 2024. Estimates for the following years are $0.43 in 2026, $0.43 in 2027, and $0.9 in 2028.

What is MiMedx Group’s revenue forecast?

MiMedx Group's average annual revenue forecast for its fiscal year ending in December 2025 is $377.04M, reflecting a 8.07% increase from the reported $348.88M in 2024. The forecast for 2026 is $428.13M, followed by $471.8M for 2027, and $553.89M for 2028.

What is MiMedx Group’s net income forecast?

MiMedx Group's net income forecast for the fiscal year ending in December 2025 stands at $44.54M, representing an 5.00% increase from the reported $42.42M in 2024. Projections indicate $67.2M in 2026, $63.03M in 2027, and $131.37M in 2028.